Clinical Trial Update: Pimavanserin and Aggression and Social Cognition. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Pimavanserin for aggression and social cognition in Intermittent Explosive Disorder; currently recruiting at Ohio State Univer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Explosive Disorder

Drugs mentioned

• Pimavanserin (pimavanserin)

Snippet

Sponsor: Ohio State University | Conditions: Intermittent Explosive Disorder | Phase 2 | Status: RECRUITING